Hemogenyx Pharmaceuticals Plc (LON:HEMO)
London
· Delayed Price · Currency is GBP · Price in GBX 690.00
-113.00 (-14.07%)
Apr 28, 2026, 5:07 PM GMT
Hemogenyx Pharmaceuticals Market Cap
Hemogenyx Pharmaceuticals has a market cap or net worth of 44.34 million as of April 28, 2026. Its market cap has increased by 542.77% in one year.
Market Cap
44.34M
Enterprise Value
46.27M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
690.00
Market Cap Chart
Since October 6, 2017, Hemogenyx Pharmaceuticals's market cap has increased from 10.68M to 44.34M, an increase of 315.08%. That is a compound annual growth rate of 18.09%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| hVIVO | 53.24M |
| Ondine Biomedical | 64.94M |
| 4basebio | 78.16M |
| Faron Pharmaceuticals Oy | 81.80M |
| Poolbeg Pharma | 32.08M |
| Bioventix | 88.82M |
| Sareum Holdings | 28.30M |
| ImmuPharma | 28.08M |